Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8,122,625
-
Total 13F shares
-
2,477,740
-
Share change
-
-179,648
-
Total reported value
-
$23,303,869
-
Price per share
-
$9.40
-
Number of holders
-
30
-
Value change
-
-$1,663,831
-
Number of buys
-
9
-
Number of sells
-
6
Institutional Holders of LUMOS PHARMA INC - Common Stock (LUMO) as of Q1 2022
As of 31 Mar 2022,
LUMOS PHARMA INC - Common Stock (LUMO) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,477,740 shares.
The largest 10 holders included
Blackstone Inc., GOLDMAN SACHS GROUP INC, WELLS FARGO & COMPANY/MN, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, NEA Management Company, LLC, PRICE T ROWE ASSOCIATES INC /MD/, Jefferies Group LLC, BlackRock Inc., and Lion Point Capital, LP.
This page lists
30
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.